SOURCE: Advanced Refractive Technologies

August 01, 2005 16:34 ET

VisiJet, Inc. Debuts as Advanced Refractive Technologies; New Ticker Symbol

SAN CLEMENTE, CA -- (MARKET WIRE) -- August 1, 2005 -- Advanced Refractive Technologies (OTC BB: ARFR) confirmed today that the Company has officially changed its name from VisiJet, Inc. The new corporate name, approved by the shareholders last month, more correctly describes the core business of the company, which is to identify, develop and market innovative technologies that will advance the various refractive and corrective, ophthalmic surgical markets.

In addition to the new corporate name, as of last Thursday, July 28, 2005, Advanced Refractive Technologies began trading in the U.S. under the ticker symbol ARFR, an Over-the-Counter, Bulletin Board listing.

Several new and improved refractive surgery techniques, such as Advanced Refractive's Epi-LASIK system, are currently revolutionizing the laser vision correction market. According to a review of new laser vision techniques on www.allaboutvision.com, "Since Epi-LASIK utilizes neither a blade nor alcohol... patients are likely to feel less pain than in alcohol procedures and to heal faster."

To read the entire article, go to (http://www.allaboutvision.com/visionsurgery/other.htm).

Advanced Refractive Technologies is also nearing commencement of the necessary FDA approval process for its break-through waterjet-based, cataract emulsifier -- Pulsatome®. Cataract surgery is the most frequently performed surgery in the United States, and according to the National Eye Institute (www.nei.nih.gov), more than half of all Americans by age 80 either have a cataract, or have had cataract surgery.

About Advanced Refractive Technologies:

Advanced Refractive Technologies, formerly known as VisiJet, Inc., is a medical device company based in Southern California that is focused on the identification, development and marketing of innovative ophthalmic applications. The company recently received FDA approval for its EpiLift system, a next-generation, ophthalmic surgical device designed for separating corneal tissue. The EpiLift system is the cornerstone of a new improvement in LASIK surgery called Epi-LASIK. The EpiLift system improves upon existing technologies using a unique separating method that eliminates many postoperative problems. Advanced Refractive Technologies holds a license from Gebauer Medizintechnik GmbH, a German engineering firm, which developed and manufactures the EpiLift System.

In addition to the EpiLift system, Advanced Refractive Technologies is currently developing a system for cataract surgery known as Pulsatome®. The Pulsatome® cataract emulsifier is a device that utilizes the company's proprietary and patented waterjet technology to remove cataracts -- the most frequently performed surgical procedure in the world. Both the EpiLift and Pulsatome systems are designed to help surgeons provide faster, safer and more efficacious procedures in what are two of the largest surgical markets in the world: refractive and cataract surgeries.

For additional information please visit: www.advancedrefractive.com

This release contains forward-looking statements that reflect the company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company's quarterly, annual and other regular filings.

Contact Information

  • Contact:
    Advanced Refractive Technologies
    Norman Schwartz
    949-940-1300 ext. 326
    Email Contact
    or
    Equitilink LLC
    Investor Relations
    877-788-1940 toll-free
    858-824-1940 local or intl.